ZA200708445B - Preventive or remedy for depression or anxiety neurosis - Google Patents

Preventive or remedy for depression or anxiety neurosis

Info

Publication number
ZA200708445B
ZA200708445B ZA200708445A ZA200708445A ZA200708445B ZA 200708445 B ZA200708445 B ZA 200708445B ZA 200708445 A ZA200708445 A ZA 200708445A ZA 200708445 A ZA200708445 A ZA 200708445A ZA 200708445 B ZA200708445 B ZA 200708445B
Authority
ZA
South Africa
Prior art keywords
remedy
preventive
depression
anxiety neurosis
neurosis
Prior art date
Application number
ZA200708445A
Other languages
English (en)
Inventor
Hirai Keisuke
Miyamoto Masaomi
Original Assignee
Takeda Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37073564&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA200708445(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Takeda Pharmaceutical filed Critical Takeda Pharmaceutical
Publication of ZA200708445B publication Critical patent/ZA200708445B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
ZA200708445A 2005-04-04 2006-04-03 Preventive or remedy for depression or anxiety neurosis ZA200708445B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2005107674 2005-04-04

Publications (1)

Publication Number Publication Date
ZA200708445B true ZA200708445B (en) 2009-03-25

Family

ID=37073564

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200708445A ZA200708445B (en) 2005-04-04 2006-04-03 Preventive or remedy for depression or anxiety neurosis

Country Status (23)

Country Link
US (1) US20090042861A1 (fr)
EP (1) EP1867641A4 (fr)
JP (1) JP5259181B2 (fr)
KR (1) KR20070118103A (fr)
CN (1) CN101189219A (fr)
AR (1) AR054435A1 (fr)
AU (1) AU2006231752B2 (fr)
BR (1) BRPI0607684A2 (fr)
CA (1) CA2602267A1 (fr)
CL (1) CL2009000980A1 (fr)
CR (1) CR9385A (fr)
GE (1) GEP20105001B (fr)
IL (1) IL186049A0 (fr)
MA (1) MA29677B1 (fr)
MY (1) MY142214A (fr)
NO (1) NO20075599L (fr)
NZ (1) NZ561677A (fr)
PE (1) PE20061355A1 (fr)
RU (1) RU2413510C2 (fr)
TW (1) TWI391132B (fr)
UA (1) UA89397C2 (fr)
WO (1) WO2006107019A1 (fr)
ZA (1) ZA200708445B (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2248808B1 (fr) * 2008-01-31 2014-07-16 Takeda Pharmaceutical Company Limited Agent prophylactique ou thérapeutique pour le trouble du déficit de l'attention avec hyperactivité
CA2824430A1 (fr) 2011-01-17 2012-07-26 Takeda Pharmaceutical Company Limited Comprime dispersible par voie orale
US8426461B2 (en) 2011-01-17 2013-04-23 Takeda Pharmaceutical Company Limited Orally dispersible tablet
JP6061924B2 (ja) * 2011-10-14 2017-01-18 武田薬品工業株式会社 口腔内分散性製剤
CN102718675B (zh) * 2012-06-07 2015-03-25 上海右手医药科技开发有限公司 阿戈美拉汀甲磺酸复合物及其制备方法
RU2571546C1 (ru) * 2014-07-14 2015-12-20 Государственное бюджетное образовательное учреждение высшего профессионального образования "Воронежский государственный медицинский университет имени Н.Н. Бурденко" Министерства здравоохранения Российской Федерации Способ дифференцированной диагностики и терапии синдрома ночной еды
EP3628316A4 (fr) 2017-03-30 2021-04-14 Penello Temporão, José Eduardo Composition multi-vitamines pour améliorer la fluidité verbale et réduire les symptômes d'anxiété de performance et son procédé de préparation
CN108451917A (zh) * 2018-03-22 2018-08-28 仁和堂药业有限公司 高稳定性米安色林制剂的制备方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4241013A1 (de) * 1992-12-05 1994-06-09 Boehringer Ingelheim Kg Verwendung von 2-Amino-6-n-propyl-amino-4,5,6,7-tetrahydrobenzothiazol als Arzneimittel mit antidepressiver Wirkung
NZ287872A (en) * 1994-06-10 1998-05-27 Smithkline Beecham Plc Cis and trans 3-benzopyranol compounds with a substituted carbonylamino group at position c-4, medicaments
US5780470A (en) * 1995-06-02 1998-07-14 Bristol-Myers Squibb Company Melatonergic indanyl piperazines
JP2884153B2 (ja) * 1996-03-08 1999-04-19 武田薬品工業株式会社 三環性化合物、その製造法および剤
US6034239A (en) 1996-03-08 2000-03-07 Takeda Chemical Industries, Ltd. Tricyclic compounds, their production and use
DK0885210T5 (da) * 1996-03-08 2008-10-13 Takeda Pharmaceutical Tricykliske forbindelser med bindingsaffinitet for melatoninreceptorer, deres fremstilling og anvendelse
JP3509637B2 (ja) * 1998-06-09 2004-03-22 武田薬品工業株式会社 睡眠障害予防治療剤
WO1999063977A2 (fr) * 1998-06-09 1999-12-16 Takeda Chemical Industries, Ltd. Composition pharmaceutique destinee a traiter ou prevenir les troubles du sommeil
EE200200717A (et) * 2000-06-27 2004-08-16 Taisho Pharmaceutical Co., Ltd. Ravimpreparaat ängistusneuroosi või depressiooni raviks ja piperasiiniderivaadid
US6589978B2 (en) * 2000-06-30 2003-07-08 Hoffman-La Roche Inc. 1-sulfonyl pyrrolidine derivatives
US6569887B2 (en) * 2001-08-24 2003-05-27 Dov Pharmaceuticals Inc. (−)-1-(3,4-Dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions thereof, and uses as a dopamine-reuptake
CA2459304A1 (fr) * 2001-09-13 2003-03-20 Schering Corporation Combinaison d'un antagoniste du recepteur d'adenosine a2a et d'un antidepresseur ou d'un anxiolytique
US20070088079A1 (en) * 2005-09-20 2007-04-19 Takeda Pharmaceutical Company Limited Prophylactic or therapeutic agent for sleep disorder

Also Published As

Publication number Publication date
BRPI0607684A2 (pt) 2009-09-22
KR20070118103A (ko) 2007-12-13
UA89397C2 (ru) 2010-01-25
EP1867641A4 (fr) 2010-01-13
JPWO2006107019A1 (ja) 2008-09-25
CA2602267A1 (fr) 2006-10-12
RU2413510C2 (ru) 2011-03-10
AU2006231752A1 (en) 2006-10-12
CL2009000980A1 (es) 2009-08-14
EP1867641A1 (fr) 2007-12-19
JP5259181B2 (ja) 2013-08-07
TWI391132B (zh) 2013-04-01
GEP20105001B (en) 2010-06-10
MA29677B1 (fr) 2008-08-01
NO20075599L (no) 2007-12-19
TW200719885A (en) 2007-06-01
MY142214A (en) 2010-11-15
US20090042861A1 (en) 2009-02-12
PE20061355A1 (es) 2007-01-15
IL186049A0 (en) 2008-02-09
NZ561677A (en) 2011-02-25
AU2006231752B2 (en) 2012-03-01
WO2006107019A1 (fr) 2006-10-12
AR054435A1 (es) 2007-06-27
CN101189219A (zh) 2008-05-28
CR9385A (es) 2007-12-07
RU2007140986A (ru) 2009-05-20

Similar Documents

Publication Publication Date Title
EP1759710A4 (fr) Remède ou médicament préventif pour l'arthrite
ZA200705783B (en) Amino-imidazolones for the inhibition of ß-secretase
HK1131880A1 (en) Improved electromechanical adjusting instrument
EP2053369A4 (fr) Balance de combinaison
ZA200708445B (en) Preventive or remedy for depression or anxiety neurosis
EP1787625A4 (fr) Traitement preventif/curatif de l'obesite
TWI347492B (en) Compositions and processes for photolithography
IL197146A0 (en) Composition for photoprotection
HK1102346A2 (en) Lock-drive mechanism
PL2168580T3 (pl) Środek do leczenia lub zapobiegania schizofrenii
GB0606655D0 (en) Showerpod 1
GB0607652D0 (en) Valve-operating mechanism
GB0604531D0 (en) Drawings for 1 crf-2005
EP2079799A4 (fr) Polyuréthannes autocatalyseurs
TWM299451U (en) Fixation mechanism
GB0615330D0 (en) Corcost 2006
GB0610406D0 (en) MoveClick 18
GB0619890D0 (en) Corcost 0020
GB0601236D0 (en) MoveClick 7
GB0603050D0 (en) Moveclick 10
GB0603565D0 (en) Moveclick 11
GB0603759D0 (en) MoveClick 12
GB0604523D0 (en) Corcost 3
GB0615059D0 (en) Corcost 506
GB0615058D0 (en) Corcost 406